Inflammation in Sputum and Disease Progression in COPD
Author Information
Author(s): David G Parr, Andrew J White, Darren L Bayley, Peter J Guest, Robert A Stockley
Primary Institution: University Hospitals of Coventry and Warwickshire
Hypothesis
Markers of sputum inflammation at baseline are related to subsequent disease progression in COPD.
Conclusion
Higher levels of sputum inflammatory markers are associated with a greater rate of subsequent decline in lung function in COPD patients.
Supporting Evidence
- Sputum myeloperoxidase correlated with decline in FEV1.
- LTB4 and albumin leakage correlated with TLCO decline.
- IL-8 correlated with progression of lung densitometric indices.
- Significant disease progression was demonstrated by a decline in FEV1, FVC, and gas transfer.
- Patients were reclassified into more severe GOLD categories over the study period.
Takeaway
This study found that measuring inflammation in the sputum of COPD patients can help predict how their disease will get worse over time.
Methodology
A cohort of 56 patients with chronic bronchitis was studied over four years, measuring sputum inflammation and correlating it with disease progression using physiological measures and CT densitometry.
Potential Biases
Potential bias due to changes in smoking status and treatment during the study.
Limitations
The study was limited by the exclusion of subjects with bronchiectasis and the reliance on single measurements for inflammation.
Participant Demographics
Mean age was 63 years, with 52% male and a history of chronic bronchitis.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI: 25.0 to 68.1 ml
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website